OasisLMS

Plenary 01: Opening Ceremony and Oral Abstract Presentations

Master Session: Cervical Cancer – Paving the Way to a Treatment Shift in Cervical Cancer

Antibody Drug Conjugates As an Exciting New Drug Class - Industry Symposium by ImmunoGen

Secondary Laparoscopic Cytoreduction for Recurrent Ovarian Cancer in Case of Laparoscopic Primary Debulking Surgery

Plenary 02: Oral Abstract Presentations

Master Session: Ovarian Cancer

Changing Paradigms in Endometrial Cancer Treatment - Industry Symposium by Eisai Inc.

Multidisciplinary Approach for Robotic Repair of Rectovaginal Fistula in a Patient With a History of Rectal Cancer

Featured Speaker, Dr. Tal Zaks

Master Session: Uterine Cancer - Management of Endometrial Cancer in The Molecular Era

How do we define non-eligible for Platinum in Ovarian Cancer: Impact of prior therapies and novel strategies for treatment - Industry Symposium by Novocure

Plenary 04: Surviving PARPs – Separating between Opinions and Facts

Master Session: Vulvar Cancer - Modern Management

It takes a village: Interdisciplinary management of patients with advanced cervical cancer - Industry Symposium by Seagen Inc. & Genmab

Plenary 05: Oral Abstract Presentations & Closing Ceremony

Learning the ABCs: Advancements in Biomarker-driven Care for Gynecological Malignancies - Industry Symposium by GSK

Molecular Profiling in Gynecologic Cancers: Now and Into the Future - Industry Symposium by Caris Life Sciences

Platinum-Sensitive Ovarian Cancer - Unmet Medical Need Beyond PARP Inhibitors - Industry Symposium by Mersana Therapeutics, Inc.